Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy

CONCLUSIONS: Independently from drug treatment, IPF was associated with the primary end point and therefore is a promising biomarker for the prediction of adverse cardiovascular events in patients with acute coronary syndrome treated with prasugrel or ticagrelor.REGISTRATION: https://www.CLINICALTRIALS: gov; Unique identifier: NCT01944800.PMID:36546322 | DOI:10.1161/ATVBAHA.122.318614

Source: Arteriosclerosis, Thrombosis and Vascular Biology - December 22, 2022 Category: Cardiology Authors: Dario Bongiovanni Nina Schreiner Rosanna Gosetti Katharina Mayer Dominick J Angiolillo Dirk Sibbing Stefan Holdenrieder Aida Anetsberger Moritz von Scheidt Heribert Schunkert Karl-Ludwig Laugwitz Stefanie Sch üpke Adnan Kastrati Isabel Fegers-Wustrow Isa Source Type: research